Business Context and Reporting Period
This Form 8-K is a current report filed by ChromaDex Corporation (not Niagen Bioscience, Inc.) on October 27, 2016, covering events occurring on October 21, 2016. The filing addresses corporate governance changes, specifically the appointment of a new director and committee chairperson.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive appointments and associated compensation arrangements.
Material Changes
The primary material change reported is the appointment of Kurt Gustafson to the Board of Directors and as Chairperson of the Audit Committee. This appointment triggers specific compensatory arrangements:
- Equity Grant: A nonstatutory stock option to purchase 40,000 shares of common stock, vesting in three equal annual installments.
- Cash Retainer: $30,000 annual cash retainer for director service.
- Committee Fee: $20,000 annual cash retainer for service as Audit Committee Chairperson.
- Future Eligibility: Eligibility for additional equity compensation in the future.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business operations. No specific risks or contingencies are disclosed other than the standard execution of an indemnification agreement for the new director. The filing notes that the Company is not aware of any transactions involving Mr. Gustafson requiring disclosure under Item 404(a) of Regulation S-K.
Investor Verification Checklist
- Verify the total number of outstanding shares to assess the dilution impact of the 40,000-share option grant.
- Review the Company's non-employee director compensation policy to confirm the standard nature of the cash retainers.
- Confirm the vesting schedule details for the stock options in the Company's equity incentive plan.
- Check subsequent filings for any changes to the Board composition or Audit Committee structure.